Polyphenol-enriched cocoa protects the diabetic retina from glial reaction through the sirtuin pathway

Diego A Duarte1, Mariana Ap B Rosales1, Alexandros Papadimitriou1

  • 1Renal Pathophysiology Laboratory, Investigation on Diabetes Complications, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil.

Insights

Cocoa

Area of Science:

  • Neuroscience
  • Biochemistry
  • Ophthalmology

Background:

  • Cocoa flavonoids are antioxidants with cardiovascular benefits.
  • Sirtuins (SIRTs) are sensitive to oxidation, impacting cellular health.
  • The effect of cocoa on neurodegeneration, particularly in the retina, is not well understood.

Purpose of the Study:

  • To assess the protective effects of cocoa against diabetic retinopathy.
  • To investigate the role of the Sirtuin-1 (SIRT1) pathway in cocoa's retinal protection.
  • To evaluate cocoa's impact on oxidative stress and related markers in a diabetic retina model.

Main Methods:

  • In vitro: Rat Müller cells (rMCs) exposed to high glucose or H2O2, treated with cocoa and SIRT-1 inhibitors/siRNA.
  • In vivo: Streptozotocin-induced diabetic rats received varying doses of cocoa polyphenols for 16 weeks.
  • Assessed markers included reactive oxygen species (ROS), poly(ADP-ribose) polymerase 1 (PARP-1) activity, NAD(+) levels, SIRT1 activity, acetyl-RelA/p65, glial fibrillary acidic protein (GFAP), and electroretinogram (ERG).

Main Results:

  • High glucose/H2O2 increased GFAP and acetyl-RelA/p65, while decreasing SIRT1 activity in rMCs.
  • Cocoa treatment reversed these changes, reduced ROS and PARP-1 activity, increased NAD(+), and enhanced SIRT1 activity.
  • Diabetic rats showed retinopathy markers and impaired ERG, linked to PARP-1 activation, NAD(+) depletion, and SIRT1 impairment.
  • Cocoa polyphenols dose-dependently restored these diabetic-induced alterations in vivo.

Conclusions:

  • Cocoa polyphenols protect the retina from diabetic damage by modulating the SIRT1 pathway.
  • Cocoa reduces oxidative stress and inflammation in the diabetic retina.
  • This study highlights cocoa's potential therapeutic role in managing diabetic retinopathy.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
11
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
6
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
8
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.7K